Details of the Drug

General Information of Drug (ID: DM26VCZ)

Drug Name
Anti-NY-ESO-1 CAR-T cells
Indication
Disease Entry ICD 11 Status REF
Esophageal cancer 2B70 Phase 1/2 [1]
Lung cancer 2C25.0 Phase 1/2 [1]
Multiple myeloma 2A83 Phase 1/2 [1]
Synovial sarcoma 2B5A Phase 1/2 [1]
Drug Type
CAR T Cell Therapy
Cross-matching ID
TTD ID
D0LJ2S
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cancer/testis antigen 1 (NY-ESO-1) TTE5ITK CTG1B_HUMAN CAR-T-Cell-Therapy [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03638206) Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies